The Latest Breaking News from Universal Health

Despite Universal Health’s recent underperformance relative to Nasdaq, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Although Universal Health has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Apple, Nvidia, Microsoft fueled the Nasdaq, but the market is increasingly split. Tesla has a new base, with caveats. Meta is among seven actionable stocks.

The stock market's holiday-interrupted week will see whether the Nasdaq and S&P 500 can continue to bang out new highs.

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Universal Health Services, Inc. (NYSE:UHS) reported first-quarter revenue growth of 9.3% year-over-year to $3.29 billion, beating the consensus of $3.21 billion. The operating income declined by 21.2% Y/Y to $232.86 million, and the margin contracted by 274 bps to 7.1%. Acute care hospitals owned adjusted admissions increased by 5.7% Y/Y, and adjusted…